根据最新的财务报表(Form-10K),Cordlife Group Limited 的总资产为 $0,净亏损为 $0
CLIFF 的关键财务比率是什么?
Cordlife Group Limited 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Cordlife Group Limited 的收入按细分市场或地理位置如何划分?
Cordlife Group Limited 最大收入来源是 Banking,在最近的收益报告中收入为 34,586,000。就地区而言, Hong Kong 是 Cordlife Group Limited 的主要市场,收入为 9,853,000。
Cordlife Group Limited 是否盈利?
否,根据最新的财务报表,Cordlife Group Limited 的净亏损为 $0
Cordlife Group Limited 有负债吗?
否,Cordlife Group Limited 的负债为 0
Cordlife Group Limited 的流通股有多少?
Cordlife Group Limited 的总流通股为 0
关键数据
前收盘价
$0.1504
开盘价
$0.0901
当日区间
-
52周范围
-
交易量
2.1K
平均成交量
--
股息收益率
--
每股收益(TTM)
--
市值
--
什么是 CORDLIFE GROUP LIMITED?
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The firm's principal activities involve investment holding and the provision of cord blood banking services. Its segments include Banking and Diagnostics. The Banking segment comprises of the banking of samples such as cord blood, cord lining and cord tissue. Cord blood, cord lining and cord tissue are collected, processed, and stored in the various laboratories. The Diagnostics segment comprises diagnostic testing such as non-invasive prenatal testing service, newborn metabolic screening, newborn genetic screening, and pediatric vision screening services. Its subsidiaries include Cordlife (Hong Kong) Limited, Cordlife Stem Cell Technology Limited, Healthbaby Biotech (Hong Kong) Co., Limited, Cordlife Technologies Pte. Ltd., CS Cell Technologies Pte. Ltd., Stemlife Berhad, and Shanghai Cordlife Biomedical Research Co., Ltd.